Cytokinetics Inc (NAS:CYTK)
$ 59.23 -0.91 (-1.51%) Market Cap: 6.21 Bil Enterprise Value: 6.44 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 41/100

Cytokinetics Inc ACC.23 Conference Call Transcript

Mar 06, 2023 / 01:30PM GMT
Release Date Price: $39.13 (-6.72%)
Operator

Good morning, and welcome, ladies and gentlemen, to Cytokinetics' ACC '23 Conference Call. At this time, I'd like to inform you that this call is being recorded. (Operator Instructions)

I will now turn the call over to Diane Weiser, Senior Vice President of Corporate Communications and Investor Relations. Please go ahead.

Diane Weiser
Cytokinetics, Incorporated - SVP

Good morning, and thanks for joining us here in New Orleans and on the call today to discuss the data from Cohort 4 REDWOOD-HCM (inaudible) FOREST-HCM (inaudible) treatment of hypertrophic cardiomyopathy. Here with me today are Robert Blum, President and Chief Executive Officer, who will make opening remarks; and Fady Malik, EVP of Research and Development who will lead (inaudible). We are honored to have Dr. Ahmad Masri, Director of the Hypertrophic Cardiomyopathy Center at Oregon Health & Science University and Dr. Sara Saberi, Assistant Professor of Internal Medicine at University of Michigan Health and Frankel Cardiovascular Center, here with us to present the data.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot